In light of these findings, FN1 and FAM20A should receive further experimental investigation to evaluate whether either can be a potential candidate for diagnostic biomarkers for early diagnosis of HCC in high-risk population for HCC, but with normal serum AFP, and be prognostic predictors of post-surgical outcomes for HCC in them. This evidence concerns the gene AFP and hepatocellular carcinoma.